Delivery Order SPE2DR25D1109-SPE2DR26FFF3V
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order contract valued at $38,627.45 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (90-count) on July 22, 2025, with completion expected by July 23, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,221.08 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (90-count units) under a firm fixed price arrangement. The award was issued on September 19, 2025, with an ultimate completion date of September 22, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a non-set-aside, competitively awarded procurement in support...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (90 count) under a firm fixed-price contract valued at $8,854.17. The order was competitively awarded without set-aside designation and is scheduled for completion by October 21, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location. This delivery order represents a transaction...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,291.93 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (90-count units). This competitively awarded, firm fixed-price contract was issued on September 3, 2025, with an ultimate completion date of September 4, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order carries no set-aside designation, reflecting the competitive nature of...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,914.29 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (90-count packaging) on August 26, 2025, with an ultimate completion date of August 27, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's role...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,855.36 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (90-count units) with a firm fixed price structure. The contract is non-set-aside and competitively awarded, with an ultimate completion date of September 2, 2025. AmerisourceBergen will perform this delivery order from its corporate headquarters in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a $3,326.40 delivery order to AmerisourceBergen Drug Corp for Gemtesa 75 mg tablets (90-count supply) on September 17, 2025, with completion scheduled for September 18, 2025. This competitively awarded, firm fixed-price contract includes no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,506.04 to AmerisourceBergen Drug Corp for Gemtesa 75 mg tablets (90-count supply). This firm fixed-price delivery order, awarded on July 2, 2025, with an ultimate completion date of July 3, 2025, represents a non-competitive, non-set-aside procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA. The product will be delivered to AmerisourceBergen's corporate headquarters in...
- The Defense Logistics Agency awarded a delivery order valued at $9,503.28 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (30-count units) on July 23, 2025, with an ultimate completion date of July 24, 2025. This firm fixed price, competitively awarded delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency awarded a delivery order valued at $13,881.40 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (90 count) on July 25, 2025, with an ultimate completion date of July 28, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- SPE2DR25D1109Indefinite Delivery Contract
- SPE2DR25D1109-SPE2DR26FFF3VDelivery Order
The Defense Logistics Agency (DLA) awarded a $2,747.46 delivery order contract to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (90-count units) with an ultimate completion date of October 21, 2025. This competitively awarded, non-set-aside delivery order utilizes firm fixed pricing and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, regularly supports federal medical procurement needs through the DLA supply chain. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime contract vehicle running through December 2026 that enables comprehensive pharmaceutical support for military and federal healthcare systems worldwide. The IDC encompasses a broad portfolio of pharmaceutical products, medical supplies, vaccines, and specialty medications across multiple therapeutic domains, supporting customers including the Defense Health Agency and U.S. Coast Guard. The current delivery order represents a routine pharmaceutical procurement supporting federal military healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 10/20/25 |